Ms Jennifer Levy > Kirkland & Ellis LLP > Washington DC, United States > Lawyer Profile
Kirkland & Ellis LLP Offices
1301 Pennsylvania Avenue, N.W.
Washington, D.C., 20004
DISTRICT OF COLUMBIA
United States
- Firm Profile
- Go to...
Ms Jennifer Levy
Position
Jenny Levy is a litigation partner who has been with Kirkland for 23 years. She has appeared before trial courts and arbitration panels across the country. Jenny focuses on complex commercial litigation, state Attorney General litigation and investigations, pharmaceutical litigation, and product liability cases. She has litigated a wide variety of cases including consumer protection actions, public nuisance claims, allegations of fraud and misrepresentation, data breaches, breach of contract, business torts, product liability, antitrust, false claims qui tam actions, and class actions. Her practice has involved a diverse array of subject matters and allegations including Public Nuisance, Medicaid/Medicare fraud, drug pricing fraud and unfair competition (AWP/WAC inflation), HIPAA, HITECH violations, contracts for the sale of energy, state and federal Fair Debt Collection Act violations, collection contracts for the sale of businesses and stock purchase agreements, alleged violations of shareholder agreements, international licensing agreements, allegations of unlawful insurance practices, conspiracy and antitrust violations, and numerous product liability cases on behalf of manufacturers of automotive products, lead products, tobacco and pharmaceuticals. Jenny is a pro bono coordinator for Kirkland’s Washington, D.C. office.
Lawyer Rankings
United States > Government > State attorneys general
With extensive bipartisan expertise, Kirkland & Ellis LLP‘s state attorneys general team draws on the experience of former senior government officials, including Chicago-based Lisa Madigan, who served as Illinois state attorney general. In Washington DC, Jennifer Levy leads on multistate litigation involving product liability cases on behalf of pharmaceuticals, manufacturing and automotive companies. Also in Washington DC is Reginald Brown, whose practice focuses on assisting financial institutions, energy companies and tech firms with regulatory and reputational matters. Another key name is former federal judge Mark Filip, who splits his time between Chicago and Washington DC and has been particularly active in representing multinational pharmaceuticals and life sciences companies in civil and criminal investigations.
United States > Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
Noted for its ‘highly strategic approach’, which combines first-chair trial skills, alongside deep subject knowledge and procedural expertise, Kirkland & Ellis LLP is a popular choice among life sciences and pharma companies facing down high-stakes, bet-the-company litigation. Jennifer Levy in Washington DC and Chicago-based Donna Welch have been pivotal to the firm’s success in the area, most notably for their ‘outstanding’ work on behalf of Allergan, as one of the defendants accused in private and government-led litigation for its role in fuelling the opioid epidemic in the US. ‘Well-respected’ Washington-DC-based trial lawyer Mike Brock is also a key member of the team and has notched up numerous successes for pharma and life sciences companies, particularly in product liability and mass tort cases.
Lawyer Rankings
- Product liability, mass tort and class action - defense: pharmaceuticals and medical devices United States > Dispute resolution
- State attorneys general United States > Government
Top Tier Firm Rankings
- Media, technology and telecoms > Advertising and marketing: litigation
- Finance > Capital markets: high-yield debt offerings
- International Trade > CFIUS
- Antitrust > Civil litigation/class actions: defense
- Government > Government relations
- Intellectual property > Copyright
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Energy > Energy litigation: oil and gas
- Energy > Energy transactions: electric power
- Energy > Energy transactions: oil and gas
- Environment > Environment: transactional
- Dispute resolution > General commercial disputes
- Tax > International tax
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Intellectual property > Patents: litigation (full coverage)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Real estate > Real estate
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Securities litigation: defense
- M&A/corporate and commercial > Shareholder activism
- Media, technology and telecoms > Technology transactions
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Intellectual property > Trademarks: litigation
- Tax > US taxes: non-contentious
Firm Rankings
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Antitrust > Cartel
- Energy > Energy regulation: electric power
- Environment > Environment: litigation
- Media, technology and telecoms > Media and entertainment: litigation
- Antitrust > Merger control
- Media, technology and telecoms > Outsourcing
- Intellectual property > Patents: licensing
- Intellectual property > Patents: litigation (International Trade Commission)
- Dispute resolution > Product liability, mass tort and class action - defense: automotive/transport
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Finance > Project finance
- Real estate > Real estate investment trusts (REITs)
- Government > State attorneys general
- Finance > Structured finance: securitization
- Tax > US taxes: contentious
- Dispute resolution > E-discovery
- Dispute resolution > Financial services litigation
- Insurance > Insurance: non-contentious
- Energy > Renewable/alternative power
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Energy > Energy regulation: oil and gas
- Dispute resolution > Leading trial lawyers
- Healthcare > Life sciences
- Media, technology and telecoms > Media and entertainment: transactional
- Real estate > Construction (including construction litigation)
- International Trade > Customs, export controls and economic sanctions
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Investment fund formation and management > Mutual/registered/exchange-traded funds